Eureka 93 Inc. has secured binding letters of intent with new and existing arm’s length partners to expand the company’s infrastructure for future CBD-infused products. The agreements are expected to be funded from the company’s future cash flows. Subject to the execution of definitive agreements, and at no additional cost to Eureka93, the company is expanding its current relationship with PRO-DIP® for exclusive global rights to its delivery technology, as well as solidifying an agreement with Neobourne Pharma for the exclusive manufacturing rights to internationally renowned effervescent brand, Brioschi®. These relationships are expected to deliver new revenue streams, provide access to distribution networks across North America, and serve as the underpinning of future CBD-products. Eureka93 has already generated revenue from PRO-DIP® products and has received an order from Brioschi®. The value of the existing production is not expected to be material to Eureka93’s total consolidated revenue for 2019. Additional details about subsequent product launches will be revealed at a later date. PRO-DIP®Partnership Extension: Building on its long-standing relationship with PRO-DIP®, a patent-pending world leader in nutritional oral pouch delivery system for nutraceuticals, the 10-year partnership will see Eureka93 acquire exclusive global rights to the delivery technology for existing products and possible future CBD and other cannabinoids, as well as the manufacturing of all future products. Introduced in 2018, PRO-DIP® has a projected 92% share of the energy pouch market, and recently signed a national distribution agreement adding to their existing regional distribution channels, thereby increasing their exposure in the U.S. and greater North American retail markets. Formulated by Eureka93 and for sale in the United States since May 2019, the current highly-differentiated product delivers flavourful bursts of vitamins and natural energy supplements through small, semi-permeable sachets placed in the mouth, between the gum and cheek or lip. The initial burst of supplements is followed by extended absorption of the nutrients through normal digestion, providing long-lasting energy, even at high-exertion levels. With its ease of consumption, the energy-rich pouches are an alternative to traditional sports supplements, and deliver a daily serving of natural vitamins and nutrients for the endurance and stamina required during exercise and sports. By maximizing existing delivery mechanisms, Eureka93 plans to evolve the technology it has already developed, manufactured, and licensed to create new general health and sports-related offerings infused with CBD. Brioschi® Agreement: As an internationally recognized brand for more than 100 years, Brioschi® is known for its efficacy as an antacid, which is currently a global multi billion-dollar growing market. The five-year agreement with Neobourne Pharma will see Eureka93 exclusively manufacture Brioschi® products for North America, including new-to-market, individual stick packs and fibre that will be in available in August 2019. Additionally, Eureka93 will conduct research on future effervescent CBD product formulations for the general health and wellness markets. Opportunities with the Brioschi® brand or other CBD products would include food-related items for stomach inflammation and irritation. The agreement also offers the opportunity for Eureka93 to leverage Neobourne Pharma’s extensive distribution network across the United States and international markets, as well as its relationships in beverage and food and other categories. All research, formulation development, and manufacturing of Brioschi® and PRO-DIP® products currently takes place at Eureka93’s Windsor, Ontario, facility, which contains 20 pharmaceutical-grade clean rooms, is certified by Health Canada, has NSF certifications for GMP and Sport, is a USDA-Certified Organic Manufacturer, and is an FDA-registered facility.